Interaction with caveolin-1 modulates G protein coupling of mouse β3-adrenoceptor

Journal of Biological Chemistry

Volumn 287, Issue 24, 2012, Pages 20674-20688

  Sato, Masaaki ^a,b   Hutchinson, Dana S ^a   Halls, Michelle L ^a   Furness, Sebastian G B ^a   Bengtsson, Tore ^b   Evans, Bronwyn A ^a   Summers, Roger J ^a  

^a MONASH UNIVERSITY   (Australia)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLYL CYCLASE; ADIPOCYTES; C TERMINUS; CAVEOLIN; CAVEOLIN-1; DIFFERENTIAL SIGNALING; G PROTEIN; G PROTEIN COUPLED RECEPTORS; IN-SITU; ISOFORMS; KNOCK OUTS; MEMBRANE PREPARATION; MULTI-PROTEIN COMPLEX; PERTUSSIS TOXIN; SCAFFOLD PROTEIN; SIGNALING PROTEINS; WILD TYPES;

MAMMALS; PROTEINS; SIGNALING;

SCAFFOLDS (BIOLOGY);

BETA 3 ADRENERGIC RECEPTOR; CAVEOLIN 1; CYCLIC AMP; FILIPIN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; BINDING SITE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; GLUCOSE TRANSPORT; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; AMINO ACID MOTIFS; AMINO ACID SUBSTITUTION; ANIMALS; CAVEOLIN 1; CHO CELLS; CRICETINAE; CRICETULUS; DIOXOLES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; MEMBRANE MICRODOMAINS; MICE; MICE, KNOCKOUT; MUTATION, MISSENSE; PROTEIN ISOFORMS; RECEPTORS, ADRENERGIC, BETA-3; SIGNAL TRANSDUCTION;

MUS;

EID: 84862001880     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.280651     Document Type: Article

References (59)

1. Simons, K., and Ikonen, E. (1997) Functional rafts in cell membranes. Nature 387, 569-572 (Pubitemid 27248754)
2. Sharma, P., Varma, R., Sarasij, R. C., Ira, Gousset, K., Krishnamoorthy, G., Rao, M., and Mayor, S. (2004) Nanoscale organization of multiple GPI-anchored proteins in living cell membranes. Cell 116, 577-589 (Pubitemid 38264434)
3. Patel, H. H., Murray, F., and Insel, P. A. (2008) G-protein-coupled receptor- signaling components in membrane raft and caveolae microdomains. Handb. Exp. Pharmacol. 186, 167-184
4. Parton, R. G., and Simons, K. (2007) The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 8, 185-194
5. Hill, M. M., Bastiani, M., Luetterforst, R., Kirkham, M., Kirkham, A., Nixon, S. J., Walser, P., Abankwa, D., Oorschot, V. M., Martin, S., Hancock, J. F., and Parton, R. G. (2008) PDRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 132, 113-124
6. Parton, R. G., Hanzal-Bayer, M., and Hancock, J. F. (2006) Biogenesis of caveolae. A structural model for caveolin-induced domain formation. J. Cell Sci. 119, 787-796
7. Lajoie, P., Goetz, J. G., Dennis, J. W., and Nabi, I. R. (2009) Lattices, rafts, and scaffolds. Domain regulation of receptor signaling at the plasma membrane. J. Cell Biol. 185, 381-385
8. Lajoie, P., Partridge, E. A., Guay, G., Goetz, J. G., Pawling, J., Lagana, A., Joshi, B., Dennis, J. W., and Nabi, I. R. (2007) Plasma membrane domain organization regulates EGFR signaling in tumor cells. J. Cell Biol. 179, 341-356 (Pubitemid 350004897)
9. Head, B. P., and Insel, P. A. (2007) Do caveolins regulate cells by actions outside of caveolae? Trends Cell Biol. 17, 51-57 (Pubitemid 46199179)
10. 2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 100, 10776-10781
11. 1-adrenergic receptor modulates receptor trafficking and signaling in cardiac myocytes. J. Biol. Chem. 277, 33783-33790
12. 2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction. J. Biol. Chem. 283, 24659-24672
13. 2-adrenergic regulation. Proc. Natl. Acad. Sci. U.S.A. 103, 7500-7505
14. 2-adrenergic signaling in adult rat ventricular myocytes. Cardiovasc. Res. 69, 816-824
15. Cohen, A. W., Razani, B., Schubert, W., Williams, T. M., Wang, X. B., Iyengar, P., Brasaemle, D. L., Scherer, P. E., and Lisanti, M. P. (2004) Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes 53, 1261-1270 (Pubitemid 38569012)
16. 3-adrenergic receptor agonist CL316243. Effects of caveolin-1 knockdown on formation/maintenance of macromolecular signaling complexes. Biochem. J. 424, 399-410
17. Cohen, A. W., Schubert, W., Brasaemle, D. L., Scherer, P. E., and Lisanti, M. P. (2005) Caveolin-1 expression is essential for proper nonshivering thermogenesis in brown adipose tissue. Diabetes 54, 679-686 (Pubitemid 40326265)
18. 3- adrenergic, but unaffected LPA, PDGF, and EGF receptor signaling. Biochim. Biophys. Acta 1803, 983-989
19. Mattsson, C. L., Csikasz, R. I., Shabalina, I. G., Nedergaard, J., and Cannon, B. (2010) Caveolin-1-ablated mice survive in cold by nonshivering thermogenesis despite desensitized adrenergic responsiveness. Am. J. Physiol. Endocrinol. Metab. 299, E374-E383
20. 3- adrenoceptor which are differentially expressed in mouse tissues. Br. J. Pharmacol. 127, 1525-1531
21. 3b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signaling pathways. Br. J. Pharmacol. 135, 1903-1914
22. 3-adrenoceptor associated with differential G protein coupling. J. Pharmacol. Exp. Ther. 315, 1354-1361
23. Couet, J., Li, S., Okamoto, T., Ikezu, T., and Lisanti, M. P. (1997) Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem. 272, 6525-6533 (Pubitemid 27118133)
24. Nevins, A. K., and Thurmond, D. C. (2006) Caveolin-1 functions as a novel Cdc42 guanine nucleotide dissociation inhibitor in pancreatic beta-cells. J. Biol. Chem. 281, 18961-18972 (Pubitemid 44035399)
25. Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., Schedl, A., Haller, H., and Kurzchalia, T. V. (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293, 2449-2452 (Pubitemid 32917325)
26. Néchad, M., Kuusela, P., Carneheim, C., Björntorp, P., Nedergaard, J., and Cannon, B. (1983) Development of brown fat cells in monolayer culture. I. Morphological and biochemical distinction from white fat cells in culture. Exp. Cell Res. 149, 105-118
27. 3-adrenoceptor deficiency in brown adipocyte norepinephrine-stimulated glucose uptake. Endocrinology 146, 2271-2284
28. Nevzorova, J., Bengtsson, T., Evans, B. A., and Summers, R. J. (2002) Characterization of the β-adrenoceptor subtype involved in mediation of glucose transport in L6 cells. Br. J. Pharmacol. 137, 9-18 (Pubitemid 34983459)
29. 3-adrenergic agonist BRL37344 increases glucose transport into L6 myocytes through a mechanism different from that of insulin. J. Biochem. 122, 90-95
30. Kaslow, H. R., Lim, L. K., Moss, J., and Lesikar, D. D. (1987) Structure-activity analysis of the activation of pertussis toxin. Biochemistry 26, 123-127 (Pubitemid 17014420)
31. Moss, J., Stanley, S. J., Burns, D. L., Hsia, J. A., Yost, D. A., Myers, G. A., and Hewlett, E. L. (1983) Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase activities of Bordetella pertussis toxin (islet-activating protein). J. Biol. Chem. 258, 11879-11882
32. i3 involves the C-terminal Arg-752 and localization within membrane Raft microdomains. Mol. Pharmacol. 75, 415-428
33. 35S]GTPγS binding as an index of total G-protein and Gα-subtype-specific activation by GPCRs. Methods Mol. Biol. 746, 263-275
34. i. Am. J. Physiol. Endocrinol. Metab. 291, E704-E715
35. 3-adrenoceptor revealed by SR59230A [3-(2-ethylphenoxy)-1-[(1S) -1,2,3,4-tetrahydronapth- 1-ylamino]-2S-2-propanol oxalate]. J. Pharmacol. Exp. Ther. 312, 1064-1074
36. Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K. J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L. G., and Landegren, U. (2006) Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995-1000 (Pubitemid 44782698)
37. 3- adrenoceptors through a cAMP, PKA, and PI 3-kinase-dependent pathway stimulating conventional and novel PKCs. Endocrinology 145, 269-280
38. Abrami, L., Fivaz, M., Kobayashi, T., Kinoshita, T., Parton, R. G., and van der Goot, F. G. (2001) Cross-talk between caveolae and glycosylphosphatidylinositol- rich domains. J. Biol. Chem. 276, 30729-30736
39. Zeng, Y., Tao, N., Chung, K. N., Heuser, J. E., and Lublin, D. M. (2003) Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1. J. Biol. Chem. 278, 45931-45936 (Pubitemid 37432739)
40. Cheng, Z. J., Singh, R. D., Holicky, E. L., Wheatley, C. L., Marks, D. L., and Pagano, R. E. (2010) Co-regulation of caveolar and Cdc42-dependent fluid phase endocytosis by phosphocaveolin-1. J. Biol. Chem. 285, 15119-15125
41. Bethani, I., Skånland, S. S., Dikic, I., and Acker-Palmer, A. (2010) Spatial organization of transmembrane receptor signaling. EMBO J. 29, 2677-2688
42. Alves, I. D., Salamon, Z., Hruby, V. J., and Tollin, G. (2005) Ligand modulation of lateral segregation of a G-protein-coupled receptor into lipid microdomains in sphingomyelin/phosphatidylcholine solid-supported bilayers. Biochemistry 44, 9168-9178 (Pubitemid 40943231)
43. 1a-adrenergic receptor occupies membrane rafts with its G protein effectors but internalizes via clathrin-coated pits. J. Biol. Chem. 283, 2973-2985
44. Allen, J. A., Yu, J. Z., Dave, R. H., Bhatnagar, A., Roth, B. L., and Rasenick, M. M. (2009) Caveolin-1 and lipid microdomains regulate Gs trafficking and attenuate Gs/adenylyl cyclase signaling. Mol. Pharmacol. 76, 1082-1093
45. sα that alter the fidelity of receptor activation. Mol. Pharmacol. 50, 885-890
46. Coward, P., Chan, S. D., Wada, H. G., Humphries, G. M., and Conklin, B. R. (1999) Chimeric G proteins allow a high throughput signaling assay of Gi-coupled receptors. Anal. Biochem. 270, 242-248 (Pubitemid 29252535)
47. i in caveolae in DDT1 MF-2 smooth muscle cells. J. Biol. Chem. 272, 17858-17866
48. q-coupled protein receptors. J. Biol. Chem. 279, 34614-34623
49. q-mediated p38 mitogen-activated protein kinase activation through tyrosine kinase. Cell. Signal. 19, 1301-1308
50. Ostrom, R. S., Post, S. R., and Insel, P. A. (2000) Stoichiometry and compartmentation in G protein-coupled receptor signaling: implications for therapeutic interventions involving G(s). J. Pharmacol. Exp. Ther. 294, 407-412 (Pubitemid 30490809)
51. Razani, B., Woodman, S. E., and Lisanti, M. P. (2002) Caveolae. From cell biology to animal physiology. Pharmacol. Rev. 54, 431-467
52. Head, B. P., Patel, H. H., Roth, D. M., Murray, F., Swaney, J. S., Niesman, I. R., Farquhar, M. G., and Insel, P. A. (2006) Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J. Biol. Chem. 281, 26391-26399 (Pubitemid 44401847)
53. Varga, E. V., Stropova, D., Rubenzik, M., Wang, M., Landsman, R. S., Roeske, W. R., and Yamamura, H. I. (1998) Identification of adenylyl cyclase isoenzymes in CHO and B82 cells. Eur. J. Pharmacol. 348, R1-R2 (Pubitemid 28275599)
54. 2+- sensitive adenylyl cyclases dictate their targeting to plasma membrane lipid rafts. J. Biol. Chem. 280, 6380-6391
55. Thangavel, M., Liu, X., Sun, S. Q., Kaminsky, J., and Ostrom, R. S. (2009) The C1 and C2 domains target human type 6 adenylyl cyclase to lipid rafts and caveolae. Cell. Signal. 21, 301-308
56. Xu, W., Yoon, S. I., Huang, P., Wang, Y., Chen, C., Chong, P. L., and Liu-Chen, L. Y. (2006) Localization of the κ-opioid receptor in lipid rafts. J. Pharmacol. Exp. Ther. 317, 1295-1306 (Pubitemid 43764136)
57. 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes. Br. J. Pharmacol. 109, 1157-1163
58. Adli, H., Bazin, R., Vassy, R., and Perret, G. Y. (1997) Effects of triiodothyronine administration on the adenylyl cyclase system in brown adipose tissue of rat. Am. J. Physiol. 273, E247-E253
59. 3- adrenergic receptor affinity and density in brown adipocytes. Eur. J. Endocrinol. 145, 87-91